Introduction
Sufficient toxicological data are now available to permit use of conventional risk assessment techniques to estimate the hazards associated with human exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) (1) . In a few incidents, 2,3,7,8-TCDD has been the only congener present at toxicologically significant concentrations. More commonly, however, real-world exposures involve complex mixtures of compounds with dioxin-like activity containing up to 75 different chlorinated dibenzo-p-dioxin (PCDD), 135 chlorinated dibenzofuran (PCDF), and 75 chlorinated biphenylene (PCBE) isomers and congeners. For example, commercial polychlorinated biphenyls (PCBs) (2) , emissions from garbage-burning resource recovery plants (3) , and chemical waste incinerators (4) , foodstuffs (5) , human milk (6) , and pyrolyzed PCBs or chlorobenzenes (7, 8) all consist of complex mixtures in which 2,3,7,8-TCDD is a minor component relative to the total PCDD, PCDF, and PCBE concentration.
Such mixtures present a difficult problem for esti- (9) . Single oral dose guinea pig LD50 values have been reported for 16 different dioxins and five different furans (10) . Fewer than 25 of the 75 possible dioxin and 20 of the 135 possible furan congeners have been subjected to in vitro determination of biological activity (10 (16) , and in assessing other sources of environmental exposure, e.g., emissions from resource recovery plants (17) , and these have gained increasing acceptance as general solutions to the PCDD/PCDF mixture problem (18) . However, it must be emphasized that the only direct experimental support for this approach rests on work performed in connection with the Binghamton incident. Here alone was sufficient contaminated material (i.e., "soot") and appropriate laboratory resources available to allow in vivo comparisons of an 
Calculation of TCDD Equivalents from Chemical Data
Chemical data can be used to estimate the 2,3,7,8-TCDD equivalent concentration present in a mixture, provided that the concentrations of the relevant compounds are known and that their biological activities can be estimated. A biological end point of special concern for these compounds is carcinogenesis (1); unfortunately, only five dibenzodioxins and no dibenzofurans have been the subject of lifetime animal bioassays (10). Thus, short-term bioassay data, which are substantially more numerous, must be utilized as the basis of the equivalence calculation. The end point used in the present study to estimate relative congener potency is the single-dose oral LD50 in the guinea pig. This is advantageous, since the LD50 of the mixture in question (soot) has been experimentally determined (24) , thus allowing direct verification of the calculation. However, since there is good correlation among various short-term assays for these compounds (25-29) any differences between results from particular short-term assays should have only minor effects on the calculation (18) . Together, the dibenzodioxins and dibenzofurans account for about 19 ,ug/g "2,3,7,8-TCDD equivalents." Stalling's demonstration (12) that the soot contains a substantial concentration of PCBEs complicates the calculation substantially. The only data available relevant to the biological potency of these derivatives are measurements of the cytosolic receptor binding affinity and the cell keratinization activity of 2,3,6,7-tetraCBE (analog of 2,3,7,8-TCDD) (33) . These results suggest that 2,3,6,7-tetraCBE may have a biological potency similar to that of its structural analog, 2,3,7,8-TCDD. Unfortunately, nothing is known about the rate of metabolic detoxification of these compounds. However, in the absence of more rigorous data, it will be assumed that biphenylenes exhibit the same biological potency as the corresponding dibenzodioxins, and three times the potency of the corresponding dibenzofurans.
Even today, quantitative determination of the PCBE concentration in the soot is complicated by the absence of any reliable labeled or unlabeled biphenylene standards. As a crude estimate of their concentration, Stalling's observation that the PCBEs are present at approximately 1/15 the concentration of the PCDFs can be used. This factor, coupled with the foregoing assumption that their biological potency is three times that of the dibenzofurans implies a contribution of about 3.4 ppm from the biphenylenes. Thus, the best estimate of the overall potency of the mixture of PCDDs, PCDFs and PCBEs is ca. 22 ppm (Table 3) .
Calculation of 2,3,7,8-TCDD Equivalents from Biological Data
The best test of the various assumptions underlying the calculation of TCDD equivalents from chemical data is to perform an empirical determination of the mixture's biological potency versus 2,3,7,8-TCDD itself. Since the estimate of biological potency was based on acute guinea pig oral LD50 data, the most direct point of comparison requires experimental measurement of this parameter for the mixture. Female guinea pigs were administered a single oral dose of a benzene extract of the soot equivalent to 4, 20, 100, 500, or 1000 mg of soot/kg (24) . The soot extract's LD50 was determined to be 327 mg/kg, based on a 42-day observation period and calculated by a modification of the method of Bliss (34) . For purposes of comparison, female guinea pigs were similarly given single oral doses of 0.1, 0.5, (1) LDw for soot (mg/kg) it can be calculated that the soot has a 2,3,7,8-TCDD equivalent concentration of (19 Rg/kg)/(327 x 103) ,ug or 58 ppm.
A more demanding test of the TCDD-equivalent concept is to calculate the TCDD equivalent concentration of the soot based on a variety of exposure end points induced subehronically. Thus, Binghamton soot was incorporated into feed at concentrations of 0, 0.2, 1.9, 9.3, 46.3, and 231.5 ppm and fed to guinea pigs for 90 days (34) . In another study, 2,3,7,8-TCDD was incorporated into feed at concentrations of 0, 2, 10, 76, and 431 ppt and similarly fed to guinea pigs for purposes of comparison (35) . End points chosen were those in which significant, dose-related differences from control values were observed after subchronic exposure in both studies. These endpoints included relative (to body) thymus weights (males), percent of initial body weight (males), triglyceride levels (males) serum ALT levels (females), and incidence of hepatocellular cytoplasmic inclusion bodies (females). For the continuous data parameters, linear regression analysis was performed to obtain the best straight-line fit for exposure (expressed as ppt 2,3,7,8-TCDD or log ppt 2,3,7,8-TCDD in the feed) versus response using data from the 2, 10, and 76 ppt dose groups in the present study. Correlation coefficients were obtained for each line. Response data were normalized by expressing each value as a percentage of the corresponding control value. This was necessary to correct for small variations between the control values in each study.
Response data for a particular dose level in the Binghamton soot study were then compared to the standard curves generated above to obtain a hypothetical 2,3,7,8-TCDD concentration in the feed which would have been expected to produce the same degree of response. The "2,3,7,8-TCDD equivalent" concentration of the soot was then calculated by using Equation (2) . The particular dose levels of Binghamton soot chosen for this comparison were those in which the degree of response fell within the limits of the corresponding standard curve (1.9 ppm soot level was used).
2,3,7,8-TCDD-equivalent concentration (,ug/g) hypothetical 2,3,7,8-TCDD concentration in feed (pg/g) (2) concentration of Binghamton soot in feed (,ug/g) A different method was employed for analysis of the quantal data obtained for the incidence of hepatocellular cytoplasmic inclusion bodies. In this case, use was made of the ED50 (dose level in feed expected to produce a 50% incidence) in order to facilitate comparison of pure 2,3,7,8-TCDD with the Binghamton soot. The ED50 following 90-day exposure to the soot was calculated using previously reported incidence data (39) by a modification of the method of Bliss (36) Finally, an effective LD50 value for prolonged 2,3,7,8-TCDD exposure was similarly derived by using total dose versus mortality data from a recovery experiment in the previous investigation (34) . This was compared with corresponding calculations from the soot study to yield an equivalent concentration (ppm) by using Equation 1. Table 4 summarizes the results of calculations of the 2,3,7,8-TCDD equivalent concentration of Binghamton soot based on dose-response data from previous investigations (34, 35 
Conclusions
The acute oral LD50 of a soot sample containing a complex mixture of PCDDs, PCDFs, and PCBEs has been shown to correspond to that of a hypothetical material containing only 2,3,7,8-TCDD at 58 ppm. The corresponding 2,3,7,8-TCDD equivalent concentration calculated by using various dose-related subchronic end points ranged from 2 to 19 ppm. Conversely, using existing literature data to estimate the potency of individual congeners and the results of chemical analyses on the soot, it can be "predicted" that the soot contains ca. 22 ppm 2,3,7,8-TCDD equivalents. In light of uncertainties in the chemical analyses and toxicological determinations, as well as uncertainties in the sample congener toxicity data upon which this calculation relies, the agreement between observed and predicted concentrations is good. However, the substantial variation in the results of the "equivalents" calculation depending on endpoint chosen clearly shows that any determination based on a single end point or any calculation based on chemical concentrations has a substantial uncertainty associated with it. Nevertheless, these uncertainties will often be small in comparison to the many uncertainties and approximations inherent in a risk assessment for a single compound, such as 2,3,7,8-TCDD. It appears likely that this approach, or a conceptually similar one, will find increasing use in the evaluation of the hazard posed by complex mixtures.
